Exagen Inc.
XGN
$7.31
$0.010.14%
NASDAQ
| 06/30/2026 | 03/31/2026 | ||||
|---|---|---|---|---|---|
| Revenue | 15.23% | 4.06% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 15.23% | 4.06% | |||
| Cost of Revenue | 8.77% | -4.36% | |||
| Gross Profit | 19.72% | 10.85% | |||
| SG&A Expenses | 3.70% | -2.88% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 4.55% | -4.10% | |||
| Operating Income | 49.56% | 31.38% | |||
| Income Before Tax | 18.70% | 15.64% | |||
| Income Tax Expenses | -- | 176.92% | |||
| Earnings from Continuing Operations | 19.44% | 15.11% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 19.44% | 15.11% | |||
| EBIT | 49.56% | 31.38% | |||
| EBITDA | 61.14% | 35.66% | |||
| EPS Basic | 20.44% | 16.09% | |||
| Normalized Basic EPS | 43.22% | 24.04% | |||
| EPS Diluted | 20.44% | 16.09% | |||
| Normalized Diluted EPS | 43.22% | 24.04% | |||
| Average Basic Shares Outstanding | 1.30% | 1.18% | |||
| Average Diluted Shares Outstanding | 1.30% | 1.18% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||